TherapeuticsMD, Inc. filed its 10-K on Apr 07, 2023 for the period ending Dec 31, 2022. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | +2.46% | +6.12% | -7.56% |
05-10 | TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-29 | TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-7.56% | 23.99M | |
+7.22% | 72.5B | |
+14.07% | 9.11B | |
-11.75% | 5.07B | |
+59.61% | 5.01B | |
+2.62% | 3.85B | |
-17.54% | 2.46B | |
+21.35% | 2.44B | |
-27.82% | 2.26B | |
+25.13% | 2.27B |
- Stock Market
- Equities
- TXMD Stock
- News TherapeuticsMD, Inc.
- TherapeuticsMD, Inc. Auditor Raises 'Going Concern' Doubt